GL1X · GenesisL1 explorer

MolNFT v1 · #117624 · protein

Crystal structure of human PI3K-gamma in complex with benzimidazole inhibitor 5

5EDS · Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic…: “Crystal structure of human PI3K-gamma in complex with benzimidazole inhibitor 5”. X-ray diffraction, 2 ligands (5MT, SO4), 14 pockets (best druggability 0.82). MolNFT v1…

PDB
5EDS
Type
protein
Length
823 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
5MT, SO4
Pockets
14 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein82345% helix, 17% strandP48736

Ligands and binding sites

  • 5MT · 4-azanyl-6-[[(1~{S})-1-[6-fluoranyl-1-(3-methylsulfonylphenyl)benzimidazol-2-yl]ethyl]amino]pyrimidine-5-carbonitrile · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111330.820.8373SO4
24440.710.8263empty
3600.680.9625empty
43490.660.80325MT
5810.620.9020empty

Compared structures

  • 5EDS · Crystal structure of human PI3K-gamma in complex with benzimidazole inhibitor 5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.